Toxic epidermal necrolysis in systemic lupus erythematosus

Autoimmunity Reviews

Volumn 5, Issue 2 SPEC. ISS., 2006, Pages 160-164

  Horne, Nathanael S ^a   Narayan, Archana R ^a   Young, Rose Marie ^a   Frieri, Marianne ^a,b  

^a NASSAU UNIVERSITY MEDICAL CENTER   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

Acute Syndrome of Apoptotic Pan Epidermolysis (ASAP); FAS; Intravenous immunoglobulin (IVIG); Lupus associated TEN; SCORTEN; Systemic lupus erythematosus (SLE); Toxic epidermal necrolysis (TEN)

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN; DAPSONE; IMMUNOGLOBULIN;

ANTIBODY PRODUCTION; BODY SURFACE; CONFERENCE PAPER; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; DISEASE COURSE; HUMAN; MORTALITY; PLASMAPHERESIS; REMISSION; RISK FACTOR; SKIN BIOPSY; SYSTEMIC LUPUS ERYTHEMATOSUS; TOXIC EPIDERMAL NECROLYSIS;

EID: 31344470162     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2005.10.003     Document Type: Conference Paper

References (31)

1. J.C. Roujeau, J.P. Kelly, L. Naldi, B. Rzany, R.S. Stern, and T. Anderson Medication use and the risk of Stevens-Johnson syndrome and toxic epidermal necrolysis N Engl J Med 333 1995 1600 1609
2. J.C. Gillaume, J.C. Roujeau, J. Revuz, D. Penso, and R. Touraine The culprit drugs in 87 cases of toxic epidermal necrolysis Arch Dermatol 123 1987 1166 1170
3. J.T. Trent, R.S. Kirsner, P. Romanelli, and F.A. Kerdel Use of SCORTEN to accurately predict mortality in patients with toxic epidermal necrolysis in the United States Arch Dermatol 139 2003 39 43
4. E. Letko, D.N. Papaliodis, G.N. Papaliodis, Y.J. Daoud, A.R. Ahmed, and C.S. Foster Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature Ann Allergy Asthma Immun 94 2005 419 436
5. A.K. Abbas, and A.H. Lichtman Cellular and molecular immunology 5th edition 2005 WB Saunders Co Philadelphia
6. R. Abe, T. Shimizu, A. Shibaki, H. Nakamura, H. Watanabe, and H. Shimizu Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand Am J Pathol 162 2003 1515 1520
7. P. Wolkenstein, D. Charue, P. Laurent, J. Revuz, J.C. Roujeau, and M. Bagot Metabolic predisposition to cutanous adverse drug reactions. Role in toxic epidermal necrolysis caused by sulfonamides and anticonvulsants Arch Dermatol 131 1995 544 551
8. O. Correia, L. Delgado, J.P. Ramos, C. Resende, and J.A. Torrinha Cutaneous T-cell recruitment in toxic epidermal necrolysis. Further evidence of CD8+ lymphocyte involvement Arch Dermatolh 129 1993 466 468
9. J.C. Roujeau, and R.S. Stern Medical progress: severe adverse cutaneous reactions to drugs NEJM 331 19 1994 1272 1285
10. P. Tristani-Firouzi, M.J. Petersen, J.R. Saffle, S.E. Morris, and J.J. Zone Treatment of toxic epidermal necrolysis with intravenous immunoglobulin in children J Am Acad Dermatol 47 4 2002 548 552
11. J.C. Edberg, J.E. Salmon, and R.P. Kimberly Systemic lupus erythematosus: immunopathology J.H. Klippel P.A. Dieppe Rheumatology 2nd ed. 1998 Mosby St. Louis (MO) 7.2.1 7.2.12
12. D.D. Gladman, and M.B. Urowitz Systemic lupus erythematosus: clinical features J.H. Klippel P.A. Dieppe Rheumatology 2nd ed. 1998 Mosby St. Louis (MO) 7.1.1 7.1.18
13. S.D. Prystowsky, and J.N. Gilliam Discoid lupus erythematosus as part of a larger disease spectrum. Correlation of clinical features with laboratory findings in lupus erythematosus Arch Dermatol 111 11 1975 1448 1452
14. C. Camisa, and H.M. Sharma Vesiculobullous systemic lupus erythematosus. Report of two cases and a review of the literature J Am Acad Dermatol 9 6 1983 924 933
15. R. Mandelcorn, and N.H. Shear Lupus-associated toxic epidermal necrolysis: a novel manifestation of lupus? J Am Acad Dermatol 48 4 2003 525 529
16. J.C. Roujeau, T.N. Huynh, C. Bracq, J.C. Guillaume, J. Revuz, and R. Touraine Genetic susceptibility to toxic epidermal necrolysis Arch Dermatol 123 1987 1171 1173
17. H.L. Chan Observations on drug-induced toxic epidermal necrolysis in Singapore J Am Acad Dermatol 10 6 1984 973 978
18. S.M. Burge, and R.P. Dawber Stevens-Johnson syndrome and toxic epidermal necrolysis in a patient with systemic lupus erythematosus [letter] J Am Acad Dermatol 13 1985 665 666
19. I. Bielsa, C. Herrero, J. Font, and J.M. Mascaro Lupus erythematosus and toxic epidermal necrolysis [letter] J Am Acad Dermatol 16 6 1987 1265 1267
20. M. Moshfeghi, and H.D. Mandler Ciprofloxacin-induced toxic epidermal necrolysis Ann Pharmacother 27 12 1993 1467 1469
21. M. Jongen-Lavrencic, P.M. Schneeberger, and J.G. van der Hoeven Ciprofloxacin-induced toxic epidermal necrolysis in a patient with systemic lupus erythematosus Infection 31 6 2003 428 429
22. W. Ting, M.S. Stone, D. Racila, R.H. Scofield, and R.D. Sontheimer Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus and the spectrum of the Acute Syndrome of Apoptotic Pan-Epidermolysis (ASAP): a case report, concept review and proposal for new classification of lupus erythematosus vesiculobullous skin lesions Lupus 13 12 2004 941 950
23. T.G. Lemziakov, D.I.a. Holovchenko, P.O. Anhelutsa, S.Kh. Ter-Vartan'ian, and O.P. Ihnat'ieva Toxic epidermal necrolysis in a female patient with systemic lupus erythematosus Vrach Delo 11 1991 113 115
24. J. Pinol Aguade, J. Palou, M. Lecha, and T. Castel Focal epidermal necrolysis. A variation of lupus erythematosus of a new disease? Med Cutan Ibero Lat Am 5 1 1977 1 11
25. J. Sayag, M. Mongin, and P.J. Weiller Toxic epidermic necrolysis in acute disseminated lupus erythematosus Ann Dermatol Venereol 107 11 1980 1077 1081
26. N. Moore, M. Biour, G. Paux, E. Loupi, B. Begaud, and F. Boismare Adverse drug reaction monitoring: doing it the French way Lancet 2 8463 1985 1056 1058
27. I. Garcia-Doval, L. LeCleach, and H. Bocquet Toxic epidermal necrolysis and Stevens-Johnson syndrome: does early withdrawal of causative drugs decrease the risk of death? Arch Dermatol 136 2000 323 327
28. M. Frieri Complement-related diseases Allergy Asthma Proc 23 2002 319 324
29. I. Viard, P. Wehrli, and R. Bullani Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin Science 282 1998 490 493
30. M.D. Kazatchkine, and S.V. Kaveri Advances in immunology: immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin N Engl J Med 345 10 2001 747 755
31. J.D. Fine Management of acquired bullous skin diseases N Engl J Med 30;333 22 1995 1475 1484